Cardiac Sodium/Hydrogen Exchanger (NHE11) as a Novel Potential Target for SGLT2i in Heart Failure: A Preliminary Study.

MLA

Pérez-Carrillo, Lorena, et al. “Cardiac Sodium/Hydrogen Exchanger (NHE11) as a Novel Potential Target for SGLT2i in Heart Failure: A Preliminary Study.” Pharmaceutics, vol. 14, no. 10, Sept. 2022. EBSCOhost, https://doi.org/10.3390/pharmaceutics14101996.

APA

Pérez-Carrillo, L., Aragón-Herrera, A., Giménez-Escamilla, I., Delgado-Arija, M., García-Manzanares, M., Anido-Varela, L., Lago, F., Martínez-Dolz, L., Portolés, M., Tarazón, E., & Roselló-Lletí, E. (2022). Cardiac Sodium/Hydrogen Exchanger (NHE11) as a Novel Potential Target for SGLT2i in Heart Failure: A Preliminary Study. Pharmaceutics, 14(10). https://doi.org/10.3390/pharmaceutics14101996

Chicago

Pérez-Carrillo, Lorena, Alana Aragón-Herrera, Isaac Giménez-Escamilla, Marta Delgado-Arija, María García-Manzanares, Laura Anido-Varela, Francisca Lago, et al. 2022. “Cardiac Sodium/Hydrogen Exchanger (NHE11) as a Novel Potential Target for SGLT2i in Heart Failure: A Preliminary Study.” Pharmaceutics 14 (10). doi:10.3390/pharmaceutics14101996.